Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NCI MAMMOGRAPHY SCREENING RECOMMENDATIONS SHOULD BE REVISED

This article was originally published in The Gray Sheet

Executive Summary

NCI MAMMOGRAPHY SCREENING RECOMMENDATIONS SHOULD BE REVISED to reflect the possibility of benefit from screening women under age 50, the House Committee on Government Operations asserts in a report approved Oct. 7 by the committee. The report, entitled "Misused Science: The National Cancer Institute's Elimination of Mammography Guidelines for Women in their Forties," criticizes NCI's decision to eliminate screening guidelines for women aged 40-49 and maintains that NCI has "created confusion about the importance of mammography screening."
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002919

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel